Loading the map…

General medical practice activities · Harrow

Satheebanu

Satheebanu Ltd

ActiveLatest figures: 2024Abridged accountsCompany only11 years on the register

Private limited company registered in Harrow, classed under “General medical practice activities”.

Headline figures

FY to Dec 2024 · Company only

Turnover

For subscribers

Profit after tax

—

Not filed: small-company exemption

Net assets

For subscribers

Cash

For subscribers

Employees

For subscribers

What the numbers say

2 findings from the figures, in plain English

Written by rules from the figures on this page. Not a forecast or a credit opinion.

History

Pro
£20202021202220232024
Profit after tax—
Turnover
Net assets
Cash
Employees

Every figure for all 5 years

“—” means we did not find the figure in a source; it is never filled with an estimate.

Balance sheet and ratios

From the filed balance sheets · £

Balance sheet2021202220232024
Fixed assets
Current assets
Creditors due within a year
Net current assets
Net assets
Ratios
Current ratioCurrent assets for every £1 owed within a year
Creditors to assetsEverything owed to creditors as a share of fixed plus current assets

5 balance-sheet lines and 2 ratios, every year

A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.

Questions people ask

›What does Satheebanu do?

Private limited company registered in Harrow, classed under “General medical practice activities”.

›How much turnover does Satheebanu make?

Answered in the full report

›Is Satheebanu profitable?

Satheebanu's profit isn't public: small companies may file without a profit and loss account.

›How many people work at Satheebanu?

Answered in the full report

›Where is Satheebanu based?

Its registered office is 38 Station Road, North Harrow, Harrow, HA2 7SE, in Harrow.

›When was Satheebanu founded?

Satheebanu Ltd was incorporated on 19 February 2015.

›Is Satheebanu still trading?

The register lists Satheebanu Ltd as active.